{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:13:38Z","timestamp":1790867618801,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"DOI":"10.7759\/cureus.20529","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T10:39:04Z","timestamp":1639996744000},"source":"Crossref","is-referenced-by-count":3,"title":["Anti-NMDA Receptor Encephalitis Misdiagnosed As Generalized Anxiety Disorder: A Case Report"],"prefix":"10.7759","author":[{"given":"Liang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheli","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181cb0968","article-title":"Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit","volume":"38","author":"Davies G","year":"2010","unstructured":"Davies G, Irani SR, Coltart C, et al.. Anti-N-methyl-D-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med. 2010, 38:679-82. 10.1097\/CCM.0b013e3181cb0968","journal-title":"Crit Care Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau J","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, et al.. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008, 7:1091-8. 10.1016\/S1474-4422(08)70224-2","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/imj.12974","article-title":"Autoimmune encephalitis","volume":"46","author":"Newman MP","year":"2016","unstructured":"Newman MP, Blum S, Wong RC, Scott JG, Prain K, Wilson RJ, Gillis D. Autoimmune encephalitis. Intern Med J. 2016, 46:148-57. 10.1111\/imj.12974","journal-title":"Intern Med J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau J","year":"2007","unstructured":"Dalmau J, T\u00fcz\u00fcn E, Wu HY, et al.. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007, 61:25-36. 10.1002\/ana.21050","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.180514","article-title":"Autoimmune encephalitis: an expanding frontier of neuroimmunology","volume":"129","author":"Guan HZ","year":"2016","unstructured":"Guan HZ, Ren HT, Cui LY. Autoimmune encephalitis: an expanding frontier of neuroimmunology. Chin Med J. 2016, 129:1122-7. 10.4103\/0366-6999.180514","journal-title":"Chin Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2013.02.010","article-title":"Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay","volume":"421","author":"Suh-Lailam BB","year":"2013","unstructured":"Suh-Lailam BB, Haven TR, Copple SS, Knapp D, Jaskowski TD, Tebo AE. Anti-NMDA-receptor antibody encephalitis: performance evaluation and laboratory experience with the anti-NMDA-receptor IgG assay. Clin Chim Acta. 2013, 421:1-6. 10.1016\/j.cca.2013.02.010","journal-title":"Clin Chim Acta"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani SR","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, et al.. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain. 2010, 133:2734-48. 10.1093\/brain\/awq213","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22297","article-title":"Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia","volume":"69","author":"Lancaster E","year":"2011","unstructured":"Lancaster E, Huijbers MG, Bar V, et al.. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol. 2011, 69:303-11. 10.1002\/ana.22297","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23756","article-title":"Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels","volume":"73","author":"Boronat A","year":"2013","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N, et al.. Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol. 2013, 73:120-8. 10.1002\/ana.23756","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau J","year":"2011","unstructured":"Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011, 10:63-74. 10.1016\/S1474-4422(10)70253-2","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.02.010","article-title":"Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions","volume":"36","author":"Kuppuswamy PS","year":"2014","unstructured":"Kuppuswamy PS, Takala CR, Sola CL. Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions. Gen Hosp Psychiatry. 2014, 36:388-91. 10.1016\/j.genhosppsych.2014.02.010","journal-title":"Gen Hosp Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus F","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al.. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016, 15:391-404. 10.1016\/S1474-4422(15)00401-9","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.60.2.164","article-title":"Hashimoto encephalopathy: syndrome or myth?","volume":"60","author":"Chong JY","year":"2003","unstructured":"Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth?. Arch Neurol. 2003, 60:164-71. 10.1001\/archneur.60.2.164","journal-title":"Arch Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000278388.90370.c3","article-title":"Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal","volume":"70","author":"Iizuka T","year":"2008","unstructured":"Iizuka T, Sakai F, Ide T, et al.. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008, 70:504-11. 10.1212\/01.wnl.0000278388.90370.c3","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2013.3216","article-title":"Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis","volume":"70","author":"Kayser MS","year":"2013","unstructured":"Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol. 2013, 70:1133-9. 10.1001\/jamaneurol.2013.3216","journal-title":"JAMA Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2017.00025","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken J","year":"2017","unstructured":"Herken J, Pr\u00fcss H. Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients. Front Psychiatry. 2017, 8:25. 10.3389\/fpsyt.2017.00025","journal-title":"Front Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S82380","article-title":"Autoimmune encephalitis in psychiatric institutions: current perspectives","volume":"12","author":"Bost C","year":"2016","unstructured":"Bost C, Pascual O, Honnorat J. Autoimmune encephalitis in psychiatric institutions: current perspectives. Neuropsychiatr Dis Treat. 2016, 12:2775-87. 10.2147\/NDT.S82380","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/79510-anti-nmda-receptor-encephalitis-misdiagnosed-as-generalized-anxiety-disorder-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:14Z","timestamp":1707507254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/79510-anti-nmda-receptor-encephalitis-misdiagnosed-as-generalized-anxiety-disorder-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.20529","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,20]]}}}